麥格理:予匯控(0005.HK)目標價58.6港元 評級“遜於大市”
麥格理髮表研究報告指,匯控(0005.HK)第三季經調整除税前利潤53.48億美元,較市場預期低6%,主要由於收入較低及減值較高,且部分被良好的成本控制抵銷。該行予集團目標價58.6港元,評級“遜於大市”。
麥格理表示,集團第三季的業績表現明顯較預期差,這不僅由於短期的因素。目前集團仍然未有下一任行政總裁的新消息,該職位需要重新制定出業務計劃。由於先前集團的目標被認為太進取,該行預期市場將會進一步調低預測。
該行又認為,管理層的言論表明,集團即將會進行變革,相關的變革將會迅速及激進。該行指,集團股價相對該行覆蓋的英國銀行有溢價,預料匯控股價短期內將會受壓。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.